
🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
At Infinity Market Research, we dont just deliver data — we deliver clarity, confidence, and competitive edge.
In a world driven by insights, we help businesses unlock the infinite potential of informed decisions.
Here why global brands, startups, and decision-makers choose us:
Industry-Centric Expertise
With deep domain knowledge across sectors — from healthcare and technology to manufacturing and consumer goods — our team delivers insights that matter.
Custom Research, Not Cookie-Cutter Reports
Every business is unique, and so are its challenges. Thats why we tailor our research to your specific goals, offering solutions that are actionable, relevant, and reliable.
Data You Can Trust
Our research methodology is rigorous, transparent, and validated at every step. We believe in delivering not just numbers, but numbers that drive real impact.
Client-Centric Approach
Your success is our priority. From first contact to final delivery, our team is responsive, collaborative, and committed to your goals — because you re more than a client; you re a partner.
Recent Reports
Laboratory Degassers Market
Laboratory Funnel Market
Global Familial Amyloid Polyneuropathy Therapeutic Market Growth (Status and Outlook) 2025-2031
Sep 2025
Healthcare
Pages: 104
LPI14160
The global Familial Amyloid Polyneuropathy Therapeutic market size is predicted to grow from US$ 1590 million in 2025 to US$ 2272 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
Familial Amyloid Polyneuropathy (FAP) isa progressive, disabling and life-threatening polyneuropathy affecting the peripheral and autonomic nervous system. FAP is an autosomal transmission disorder which is usually due to a point mutation of the transthyretin (TTR) gene.The treatment of familial amyloid polyneuropathies (FAP) is complex and requires a neurological and cardiological multidisciplinary coverage. It includes specific treatments to control the progression of the systemic amyloidogenesis, the symptomatic treatment of the peripheral and autonomic neuropathy (digestive, urinary, sexual, postural hypotension) and the treatment of organs severely involved by amyloidosis (heart, eyes, kidneys).
The global familial amyloid polyneuropathy (FAP) therapeutic market refers to the market for treatments and therapies aimed at managing and treating familial amyloid polyneuropathy, also known as transthyretin amyloidosis (ATTR). FAP is a rare, progressive, and potentially fatal genetic disorder that affects the peripheral nerves and can lead to various symptoms and complications.
Here are some key points related to the global FAP therapeutic market:
Market Overview: The market for FAP therapeutics includes pharmaceutical drugs, gene therapies, and other treatment options aimed at managing the symptoms and halting the progression of the disease.
Disease-Modifying Therapies: The development of disease-modifying therapies targeting the underlying cause of FAP is a significant focus in this market. These therapies aim to reduce the buildup of abnormal amyloid proteins in the peripheral nerves, which is a hallmark of FAP.
TTR Stabilizers: TTR (transthyretin) stabilizers are pharmacological agents that aim to stabilize the mutated TTR protein and prevent its misfolding and aggregation. Several TTR stabilizers have been approved or are under investigation for their efficacy in treating FAP.
RNA Interference (RNAi) Therapies: RNAi therapies, such as patisiran and inotersen, work by reducing the production of the TTR protein by interfering with the mRNA responsible for its synthesis. These therapies have shown promise in clinical trials and have been approved for the treatment of FAP in some regions.
Liver Transplantation: In some cases, liver transplantation may be considered as a treatment option for FAP. As the liver produces most of the circulating TTR, replacing the diseased liver with a healthy one can halt the production of mutant TTR and slow down the progression of the disease.
Geographic Considerations: The global FAP therapeutic market is influenced by factors such as regional prevalence, healthcare infrastructure, regulatory environments, and reimbursement policies across different countries and regions.
Ongoing Research and Development: The FAP therapeutic market is dynamic, with ongoing research and development efforts focusing on novel therapies and treatment modalities. This includes gene therapies, small molecule inhibitors, and other approaches aimed at providing effective and targeted treatments for FAP.
Infinity Market Research newest research report, the Familial Amyloid Polyneuropathy Therapeutic Industry Forecast looks at past sales and reviews total world Familial Amyloid Polyneuropathy Therapeutic sales in 2024, providing a comprehensive analysis by region and market sector of projected Familial Amyloid Polyneuropathy Therapeutic sales for 2025 through 2031. With Familial Amyloid Polyneuropathy Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Familial Amyloid Polyneuropathy Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Familial Amyloid Polyneuropathy Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Familial Amyloid Polyneuropathy Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Familial Amyloid Polyneuropathy Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Familial Amyloid Polyneuropathy Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Familial Amyloid Polyneuropathy Therapeutic.
This report presents a comprehensive overview, market shares, and growth opportunities of Familial Amyloid Polyneuropathy Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Inotersen
Tafamidis
Patisiran
Others
Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration.
Pfizer Inc.
Alnylam Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Corino Therapeutics Inc.
Proclara Biosciences
Arcturus Therapeutics Inc
Prothena Corporation
Eidos Therapeutics
FoldRx Pharmaceuticals
Akcea Therapeutics
GlaxoSmithKline (GSK)
Greenovation Biotech GmbH
Familial Amyloid Polyneuropathy Therapeutic Market Scope
Report Attribute | Details |
---|---|
Market Size (Start Year) | USD XX Million |
Market Size (End Year) | USD XX Million |
Compound Annual Growth Rate (CAGR) | USD XX Million |
Forecast Period | USD XX Million |
Base Year | USD XX Million |
Historical Data | USD XX Million |
Key Players | USD XX Million |
📘 Frequently Asked Questions
1. What is the market size of Global Familial Amyloid Polyneuropathy Therapeutic Market?
Answer: The global Familial Amyloid Polyneuropathy Therapeutic market size is predicted to grow from US$ 1590 million in 2025 to US$ 2272 million in 2031; it is expected to grow at a CAGR of 6.1% from 2025 to 2031.
2. Which regions are analyzed in the Global Familial Amyloid Polyneuropathy Therapeutic Market report?
Answer: The Global Familial Amyloid Polyneuropathy Therapeutic Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.
3. What methodology is used for forecasting of Global Familial Amyloid Polyneuropathy Therapeutic Market?
Answer: The Global Familial Amyloid Polyneuropathy Therapeutic Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.
4. Are emerging markets analyzed separately in the Global Familial Amyloid Polyneuropathy Therapeutic Market?
Answer: Yes, the Global Familial Amyloid Polyneuropathy Therapeutic Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.
5. Does the report include competitive benchmarking of Global Familial Amyloid Polyneuropathy Therapeutic Market?
Answer: Yes, Global Familial Amyloid Polyneuropathy Therapeutic Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.
6. Can I access country-level data within the Global Familial Amyloid Polyneuropathy Therapeutic Market report?
Answer: Yes, Global Familial Amyloid Polyneuropathy Therapeutic Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.
7. Can I get customized insights or data from the Global Familial Amyloid Polyneuropathy Therapeutic Market report?
Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.
🎁 This Month Only: Flat $1000 OFF
Enjoy an exclusive $1000 discount on every report purchased this month. No code needed.

🔐 Secure Payment Guaranteed
Safe checkout with trusted global payment methods.
🌟 Why Choose Infinity Market Research?
- Accurate & Verified Data:Our insights are trusted by global brands and Fortune 500 companies.
- Complete Transparency:No hidden fees, locked content, or misleading claims — ever.
- 24/7 Analyst Support:Our expert team is always available to help you make smarter decisions.
- Instant Savings:Enjoy a flat $1000 OFF on every report.
- Fast & Reliable Delivery:Get your report delivered within 5 working days, guaranteed.
- Tailored Insights:Customized research that fits your industry and specific goals.
📄 Available License Types
